Skip to content

Topical Steroid Treatment After Posterior Lamellar Corneal Transplantation

Investigation of Treatment With Topical Corticosteroid After Posterior Lamellar Corneal Transplantation

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01682421
Enrollment
0
Registered
2012-09-11
Start date
2012-09-30
Completion date
Unknown
Last updated
2014-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Descemet's Stripping Endothelial Keratoplasty, Endothelial Dystrophy, Posterior Lamellar Keratoplasty, Secondary Bullous Keratopathy

Brief summary

After corneal transplantation, topical corticosteroids are used to reduce the risk of rejection. However, the optimal postoperative treatment regimen is unknown. In most cases, a topical steroid is administered for at least 6 months after surgery, but it remains to be determined whether potent steroids offer better protection than weak steroids. Also, the length of the treatment is debated. Since the use of steroids is not without potential serious ocular side effects, it is of considerable importance to investigate these problems. The study aims to examine the frequency of rejection episodes after posterior lamellar keratoplasty; specifically comparing a short course of potent steroids versus a long course of weak steroids.

Interventions

DRUGWeak steroid (Flurolon, Allergan)
DRUGPotent steroid (Maxidex, Alcon)

Sponsors

Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients treated for primary or secondary corneal endothelial failure at the department of ophthalmology, Aarhus University Hospital

Exclusion criteria

* Not fulfilling the above

Design outcomes

Primary

MeasureTime frame
Freedom from rejection2 years

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026